Toshinari Tamura
Board Member
Board of Directors
Fibrogen
China
Biography
Toshinari Tamura, Ph.D. has served on our board of directors since September 2008. He previously worked at Yamanouchi Pharmaceutical Co. Ltd., starting in 1972 and ultimately becoming Executive Corporate Officer and Representative Director. Following the merger with Astellas Pharma Inc., he was named Executive Vice President and Chief Science Officer of Astellas and served in those roles and on the board of directors from April 2005 until June 2008. Dr. Tamura was in charge of research and development of FibroGen’s PHI anemia program in 2004 and has remained familiar with the science of the program since then. Dr. Tamura served as director of the board of KinoPharma Inc., a drug development company, from September 2008 to March 2010. Dr. Tamura served as director of the board of IMMD Inc., a drug development company, from October 2010 to November 2012. Dr. Tamura served as an advisor to Shin Nippon Biomedical Laboratories Ltd., a drug development company, from September 2008 to August 2015. Dr. Tamura served as an advisor to Japan Science and Technology Agency, a government-sponsored organization promoting science and technology, from September 2012 to March 2015. Dr. Tamura is currently advisor to Innovation Network Corporation of Japan, a government-sponsored private equity firm (from February 2010), and Japan Agency for Medical Research and Development, a government-sponsored organization to promote integrated medical R&D (from April 2015). Dr. Tamura holds a Bachelor’s degree in Pharmaceutical Science from Chiba University, Department of Pharmaceutical Sciences, and Master’s and Ph.D. degrees in Organic Chemistry from the University of Tokyo, Graduate School of Pharmaceutical Sciences.
Research Interest
Pharmaceutical Science, Biomedical science, Business Management
